PANS and PANDAS are conditions in which a child’s immune system mistakenly attacks part of the brain, triggering a sudden, dramatic onset of obsessive-compulsive behavior, tics, anxiety, or severe food restriction. These are not gradual developments. Parents typically describe a child who seemed fine one day and was unrecognizable the next. The estimated annual incidence is about 1 in 11,765 children between ages 3 and 12, though rates vary by region.
The two terms are closely related. PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) is the broader category. PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) is a specific subtype of PANS where the trigger is a strep infection, such as strep throat or scarlet fever.
How PANS and PANDAS Differ
The key distinction is the trigger. PANDAS requires a confirmed strep infection within three months of symptom onset. A positive throat culture or strep antibody test ties the psychiatric symptoms directly to that bacterial infection. PANDAS also specifically requires the presence of OCD, a tic disorder, or both, and symptoms must begin between age 3 and puberty.
PANS casts a wider net. It can be triggered by other infections (such as Mycoplasma or various viruses), immune system problems, or environmental factors. Its hallmark is the sudden onset of OCD or severely restricted food intake, plus at least two additional neuropsychiatric symptoms. A child doesn’t need a strep history to qualify for a PANS diagnosis.
What Happens in the Brain
The leading explanation is molecular mimicry. After a strep infection, the immune system produces antibodies to fight the bacteria. But certain proteins on the surface of strep bacteria closely resemble proteins found on neurons in the basal ganglia, a brain region that helps control movement, habits, and emotions. The antibodies can’t tell the difference, so they attack the child’s own brain tissue.
Specifically, research points to these rogue antibodies targeting dopamine receptors on neurons in the basal ganglia and cortex. Dopamine is central to movement control, motivation, and reward processing. When antibodies interfere with dopamine signaling in these circuits, the result is a mix of involuntary movements (jerky, dance-like motions) and neuropsychiatric symptoms like compulsions, mood swings, and behavioral regression. Studies in mice have confirmed that transferring these antibodies causes both movement problems and behavioral changes.
Symptoms Parents Notice First
The defining feature is speed. Symptoms appear abruptly, often over the course of hours or days, not weeks or months. A child who had no behavioral concerns may suddenly:
- Develop intense OCD: repetitive handwashing, checking, counting, fear of contamination, or rigid rituals that didn’t exist before
- Refuse to eat: not typical pickiness, but severe restriction driven by fears about food texture, choking, or contamination
- Show dramatic mood changes: new anxiety, panic, depression, or explosive rage that seems completely out of character
- Lose previously mastered skills: handwriting may deteriorate noticeably, speech may regress, or a child may suddenly struggle with schoolwork they handled easily before
- Display unusual movements: jerky, involuntary motions, physical hyperactivity, or tics (repetitive blinking, throat clearing, facial grimacing)
- Experience sleep and bladder problems: new-onset insomnia, nighttime fears, frequent urination, or bedwetting in a child who had been dry for years
Another hallmark of PANDAS specifically is an episodic pattern. Symptoms may flare intensely, then partially or fully fade, then return with the next infection. Each flare can introduce new symptoms or worsen existing ones.
How It’s Diagnosed
There is no single blood test or brain scan that confirms PANS or PANDAS. Both are diagnosed clinically, meaning a provider pieces together the pattern of symptoms, their timing, and the child’s medical history. PANDAS in particular is considered a diagnosis of exclusion: other conditions that could explain the symptoms need to be ruled out first.
For PANDAS, the diagnostic criteria include OCD or tics (or both), onset between ages 3 and puberty, a confirmed strep infection close to when symptoms appeared, episodic severity, and neurological signs like involuntary movements. For PANS, the criteria center on sudden-onset OCD or severe food restriction plus at least two other neuropsychiatric symptoms from the list above, without requiring a specific infectious trigger.
This can make getting a diagnosis frustrating. Many pediatricians and psychiatrists are still unfamiliar with these conditions, and a child’s sudden behavioral changes may initially be attributed to stress, anxiety disorders, or a developmental issue. Parents who notice an abrupt, dramatic shift in their child’s behavior, particularly following an illness, often need to advocate specifically for evaluation.
Treatment Approaches
Treatment targets both the underlying immune problem and the psychiatric symptoms themselves, typically in layers depending on severity.
Treating the Infection
When strep is the identified trigger, antibiotics are the first step. Penicillin-class drugs are generally considered first-line because they effectively target strep with a narrow range of action. Some children are placed on longer-term antibiotic courses to prevent future strep infections from triggering new flares. One clinical trial found symptom improvement in children who received 12 months of antibiotic prevention, though there’s little guidance on how long this approach should continue.
Managing Psychiatric Symptoms
Cognitive behavioral therapy (CBT) has shown preliminary effectiveness for the OCD component of PANDAS. In a small study of children ages 9 to 13 who completed an intensive three-week CBT program, the approach was considered both effective and safe. CBT teaches children to recognize obsessive thoughts and gradually resist compulsive behaviors, which can provide relief even while the underlying immune issue is being addressed. Some children also benefit from medication that helps manage anxiety and obsessive symptoms during acute flares.
Immune-Targeted Therapies for Severe Cases
When standard treatments aren’t enough, more aggressive immunological interventions may be used. Intravenous immunoglobulin (IVIG), a treatment that delivers concentrated antibodies from donated blood to help reset the immune response, is often the preferred option for moderate to severe cases. In a study of 21 children with moderate to severe PANS who hadn’t responded to standard therapy, IVIG reduced obsessive-compulsive symptoms by roughly 61% over the study period, with improvements sustained for at least 8 weeks after the final infusion and up to 46 weeks in some children. Noticeable improvement typically appeared by the third infusion.
Plasma exchange, which filters the problematic antibodies directly out of the blood, has also shown effectiveness. An earlier landmark study found it reduced OCD symptoms by about 58% in children with PANDAS, while a placebo infusion had no effect.
Long-Term Outlook
A follow-up study tracked 34 children with PANS over a median of 3.3 years. Overall, clinician-rated symptom severity dropped significantly and general functioning improved. However, the trajectories varied considerably. Most children (20 out of 34) followed a relapsing-remitting course, meaning they experienced flares but spent more than half their time in remission. Only 2 were fully remitted with no symptoms for the prior 12 months. And 12 children, about a third, had a chronic or progressive course, spending more than half their time in a flare state and needing more intensive treatment.
Children with earlier onset tended to have worse long-term outcomes, with greater impairment and a higher likelihood of the chronic-progressive pattern. The encouraging finding is that the majority of children improved meaningfully over time, but the condition often requires sustained management rather than a single course of treatment. Families should expect a process that may involve multiple strategies, adjustments over time, and close monitoring for new infections or symptom flares.